Escalon Medical Corp. ESMC
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.94% | 2,329.27% | 140.73% | 36.84% | -239.89% |
| Total Depreciation and Amortization | 0.00% | -64.29% | 2.44% | -4.65% | -2.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 60.38% | -5,346.79% | 174.65% | -178.43% | -186.15% |
| Change in Net Operating Assets | -236.24% | 201.32% | -274.49% | -6.01% | 247.74% |
| Cash from Operations | -189.40% | 154.31% | -708.71% | 437.97% | -48.53% |
| Capital Expenditure | -- | -- | 100.00% | -12.82% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -206.19% | -- | -- | -- | -- |
| Cash from Investing | -100.88% | -- | 100.00% | -12.82% | -- |
| Total Debt Issued | -- | -100.00% | -- | -- | -- |
| Total Debt Repaid | 99.11% | 14.13% | -1,008.49% | -53.62% | 33.01% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 99.11% | -476.57% | -65.09% | -53.62% | 33.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.22% | 661.81% | -864.14% | 1,300.00% | -75.49% |